Physician-Led Non-Surgical Lifting & Aesthetic Medicine in Gangnam, Seoul
4.8 Google Rating (56 Reviews)
en-US
Skin Boosters · Needs Clinic Confirmation
Exosome Therapy
Exosome therapy uses exosomes — described as intercellular signalling molecules — with the stated aim of supporting skin regeneration and relieving inflammation, particularly in sensitive and damaged skin.
Schedule a ConsultationExosome Therapy

Medically reviewed by Dr. Jin-Woo Doh, Representative Director, JD Clinic, Gangnam, Seoul, and Dr. Hyunseon Kee, Director, JD Clinic
Exosome therapy uses exosomes — described as intercellular signalling molecules — with the stated aim of supporting skin regeneration and relieving inflammation, particularly in sensitive and damaged skin. JD Clinic in Gangnam, Seoul offers it within its skin booster menu. Before anything else on this page, one thing belongs at the top rather than buried in a safety section: exosome products occupy a specific and unsettled regulatory position, and a patient considering this treatment should understand that position before weighing anything else. That is set out in full below.
JD Clinic's doctor mapping is recorded at the specialty level, so this page names the doctors who direct care for this treatment area rather than claiming that one named doctor personally carries out every individual session.
What Is Exosome Therapy?
A concentrated preparation is infused into the skin after cleansing and numbing.
What the clinic describes. Exosomes as intercellular signalling molecules, used to support skin regeneration and inflammation relief.
Who it is aimed at. Sensitive, easily irritated skin; compromised skin barriers; post-treatment redness; chronic dryness; ageing skin.
Anaesthetic cream is used, and the session takes approximately twenty to thirty minutes.
Recovery is approximately one to two days.
It is planned as a course. Retreatment every two to four weeks, three or more treatments, with maintenance stated at approximately one to two months.
This page does not state that the treatment works. The clinic's records contain a claims statement describing exosomes as shown to relieve inflammation, accelerate wound recovery and rebuild skin matrices; because that is an efficacy claim with no supporting documentation supplied and no regulatory approval behind it, this page reports it as the clinic's description rather than repeating it as fact. What a treatment is offered for and what it is proven to do are different statements, and the difference is the point of this page.
Who Performs Exosome Therapy at JD Clinic
|
|
Dr. Jin-Woo Doh | Dr. Hyunseon Kee |
Care in this treatment area is directed by Dr. Jin-Woo Doh, Representative Director of JD Clinic, and Dr. Hyunseon Kee, Director.
Dr. Doh graduated from Seoul National University College of Medicine and serves as a Guest Professor at Seoul National University Hospital. Skin boosters are named among his listed core specializations.
Dr. Hyunseon Kee is a Director at JD Clinic whose listed areas are aesthetic plastic surgery, aesthetic procedures and laser-based aesthetic treatments. She is a full member of the Korean Society of Aesthetic Plastic Surgery, the International Society of Aesthetic Surgery, and the Korean Society of Aesthetic Plastic Surgery and Laser. Dr. Doh is additionally a full member of the Korean Society of Aesthetic Surgery and the Korean Society for Obesity Treatment.
JD Clinic has not provided licence or board-status records for either doctor, so none is claimed here, and no educational institution is attributed to Dr. Hyunseon Kee because the clinic's records do not state one.
The physician conducts a skin assessment evaluating barrier integrity, sensitivity level and the degree of inflammation before designing the delivery protocol. The clinic's records mark the technology and the clinic-specific technique as requiring confirmation, so this page does not describe a device or a proprietary method — and for a treatment in this regulatory position, what is actually being used is the single most important thing to establish in person.
JD Clinic describes its approach as assessing skin thickness, the degree of laxity and facial structure before selecting a device, then targeting the intended tissue layer with the minimum number of passes needed rather than applying one fixed setting to every patient.
Who Is a Good Candidate for Exosome Therapy?
The clinic's stated candidate profile is people with sensitive, easily irritated skin, compromised skin barriers, post-treatment redness, chronic dryness, or ageing skin.
Treatment is not suitable for:
Anyone with an active skin infection at the injection site
Patients with active facial malignancies
People with systemic autoimmune conditions
Anyone with known hypersensitivity to biological growth-factor complexes
Those exclusions are broader and more medical than for the clinic's other skin boosters — active malignancy and systemic autoimmune disease are not typical entries on an aesthetic exclusion list — and their presence is itself informative about the class of product involved. Anyone in those categories should regard the exclusion as firm rather than negotiable, and anyone with a condition they are unsure about should raise it before rather than during a consultation.
There is also a question of what a patient is actually hoping for, and it is worth asking yourself plainly. A compromised, reactive skin barrier is a real problem with several possible causes, some of them ordinary — over-exfoliation, an unsuitable routine, a treatment done too aggressively, a skin condition that has not been diagnosed. Those causes are addressed by identifying and removing them, and a course of regenerative injections layered on top of a barrier that is still being irritated daily is unlikely to fix what is causing the irritation. A consultation that spends time on your current skincare and recent treatments before proposing a product is doing the more useful part of the work.
The same applies to post-treatment redness, which appears on the candidate list. Redness that follows a specific procedure and is still settling is a different thing from redness that has persisted for months, and the second warrants a diagnosis before it warrants a treatment.
What to Expect: Procedure, Recovery, and Results Timeline

The skin is thoroughly cleansed, topical numbing cream is applied for comfort, and the preparation is infused into the target areas.
Stage | What happens | Timing |
|---|---|---|
Assessment | Barrier integrity, sensitivity, degree of inflammation | Before treatment |
Numbing | Anaesthetic cream | Before the session |
Treatment | Infusion into the target areas | Approximately 20–30 minutes |
Recovery | Stated period | Approximately 1–2 days |
Early effects | Redness at the treatment site | Temporary |
Course | Recommended | 3 or more treatments at 2–4 week intervals |
Maintenance | Stated period | Approximately 1–2 months |
Mild discomfort may occur, particularly where delivery is by injection or microneedling; anaesthetic cream is used to make the procedure more comfortable. Redness at the treatment site is the effect the clinic names.
Before treatment, clean the face thoroughly, avoid chemical peels or physical scrubbing, and refrain from harsh active skincare ingredients immediately beforehand. Afterwards, focus on regeneration-oriented care and avoid scrubbing and strong irritation.
Because downtime is short at one to two days, a stay of one to two days for treatment and initial recovery is generally sufficient, and patients can fly home the same day or within one to two days. The clinic operates a 24-hour post-treatment feedback system, and English-language aftercare is available through remote follow-up consultation and ongoing channels such as email and messaging once a patient has returned home.
Combining Exosome Therapy with Other Treatments
The clinic describes this treatment as frequently combined with fractional laser, microneedling or energy-based lifting treatments. Those combinations carry an additional consideration that belongs on this page: a preparation delivered into skin that has just been fractionally injured is reaching deeper and more broadly than the same preparation applied to intact skin. Where the preparation's composition and regulatory status are uncertain, that is a reason to ask more questions rather than fewer.
Alternatives include polynucleotide skin boosters and hyaluronic acid hydration micro-injections — both of which are better-characterised product classes — as well as cultured stem cell therapy, which sits in the same unsettled regulatory territory as this treatment rather than outside it. For a patient whose concern is a compromised skin barrier and persistent sensitivity, a conversation about medical skincare and avoiding further irritation is also a legitimate part of the options. More about the clinic and its team is on the JD Clinic about page.
Safety, Precision, and Clinic Standards
JD Clinic has been registered since 2023 as a Registered Medical Institution for Attracting Foreign Patients, certified by the Ministry of Health and Welfare in compliance with the Medical Overseas Expansion and Foreign Patients Attraction Act. The clinic's business registration number is 530-11-00701.
The clinic's stated quality-control process is individualised medical assessment rather than device-led selection, with treatment that is not needed avoided rather than added. Consultation and treatment are physician-led.
The regulatory position on exosome products is the most important thing on this page, and it is stated here in the regulator's own terms rather than summarised. The U.S. Food and Drug Administration states that exosome-based injectable products are, as a category, regulated in the United States as drugs and biological products subject to premarket review; that there are currently no FDA-approved exosome products; and that it has reported serious adverse events in patients treated with unapproved products marketed as containing exosomes. Its consumer alert on regenerative medicine repeats that there are currently no approved exosome products, and notes that the only approved stem cell products are blood-forming stem cells derived from umbilical cord blood for blood-production disorders.
The same regulator's patient information on regenerative medicine therapies sets out what has been reported: unapproved regenerative products, including exosomes, carry documented safety concerns reported to it including blindness, tumour formation, bacterial infections, unwanted immune responses and cross-contamination during processing. Separately, it warns that injectable products derived from human cells or tissues that lack approval have been the subject of adverse event reports including patient death, and that it has not reviewed or verified their quality, safety, purity or potency.
None of that describes this clinic, this product, or Korean regulation, which differs from United States regulation. What it describes is the category, and it is the honest context for a patient — particularly an American patient — deciding whether to have this treatment abroad. The practical questions that follow are specific: what exactly is the product, who manufactures it, what is its regulatory status in Korea, and what would the clinic do if a reaction occurred after you had returned home.
The ordinary injectable precautions apply as well. The Centers for Disease Control and Prevention notes that cosmetic procedures are among the settings where unsafe injection practices occur, and that reusing needles or syringes or mishandling medication vials can transmit hepatitis B, hepatitis C, bacterial and fungal infections and possibly HIV. The American Academy of Dermatology advises anyone considering a cosmetic treatment to establish who will perform it, ask about their experience with that specific procedure, and discuss the risks and the realistic expected result before agreeing to anything.
English-language support is provided by a dedicated international patient coordinator, Cheon Seung-yeon, Team Manager, on weekdays from 09:30 to 19:00, with Korean and Japanese coordination also available.
The Bottom Line
The clinic offers this for sensitive, damaged or compromised skin, with a course of three or more sessions.
Anaesthetic cream, twenty to thirty minutes, and a stated one-to-two-day recovery.
There are currently no approved exosome products in the United States, and serious adverse events have been reported with unapproved ones.
The exclusion list here includes active malignancy and systemic autoimmune disease — broader than an ordinary aesthetic treatment's.
Ask what the product is, who makes it, and what its regulatory status is. Those are the questions that matter here.
Frequently Asked Questions
Who is a good candidate for exosome therapy?
The clinic describes candidates as individuals with sensitive, damaged, easily irritated or ageing skin seeking skin regeneration, inflammation relief and improved barrier function. Whether that description fits you is a separate question from whether the treatment is the right choice — and the regulatory context above is part of answering the second.
Who should avoid or postpone treatment?
Anyone with an active skin infection, an uncontrolled systemic condition, an active malignancy, or a known severe hypersensitivity to biotherapy components. Systemic autoimmune conditions also appear on the clinic's exclusion list. These are firmer exclusions than for most aesthetic treatments.
How long does it take, and is it painful?
The procedure takes approximately twenty to thirty minutes. Mild discomfort may occur, especially where delivery is by injection or microneedling, and anaesthetic cream is used to make it more comfortable.
How long should I stay in Korea, and when can I fly home?
Downtime is short at one to two days, so a stay of one to two days for treatment and initial recovery is generally sufficient, and patients can fly home the same day or within one to two days.
When will I see results, and how many sessions?
The clinic describes soothing and barrier improvements starting within days, with a maintenance period of approximately one to two months after a full protocol of three or more treatments at two-to-four-week intervals. This page does not state that the treatment produces those changes; it reports what the clinic describes.
What is the regulatory position on exosome products?
In the United States, exosome-based injectable products are regulated as drugs and biological products subject to premarket review, there are currently no approved exosome products, and serious adverse events have been reported in patients treated with unapproved products marketed as containing them. Korean regulation differs, and the product's status there is a question for the clinic.
What should I ask the clinic before agreeing?
What exactly the product is and who manufactures it; its regulatory status in Korea; what reactions the clinic has seen and how it manages them; and what it would do if a problem developed after you had flown home. A clinic comfortable with all four is a better sign than any description of the treatment.
Does JD Clinic publish a price for exosome therapy?
JD Clinic does not publish treatment prices for this market; a quotation is given after an individual consultation. With three or more sessions described as a full protocol, the course rather than the session is the useful unit to discuss.
Book a Consultation at JD Clinic

If sensitive, reactive or compromised skin is what brought you here, a consultation is the right next step — and the questions above are reasonable ones to bring to it. JD Clinic is located at B2, 616 Gangnam-daero, Gangnam-gu, Seoul, Republic of Korea, and can be reached on +82-2-523-7581 or through the clinic's contact page. Consultations run Monday to Thursday from 09:30 to 19:00, Friday until 21:00 and Saturday until 16:00, with a lunch break on weekdays from 13:00 to 14:00.
International patients can start with an online enquiry through the JD Clinic contact page, and an English-speaking coordinator will follow up.
Disclaimer
This page is for general information only and is not medical advice, a diagnosis, or a treatment recommendation. Outcomes differ from person to person, and whether any treatment is appropriate for you can only be decided in a consultation with a qualified doctor.
Sources & Further Reading
Public Safety Notification on Exosome Products — U.S. Food and Drug Administration
Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration
Important Patient and Consumer Information About Regenerative Medicine Therapies — U.S. Food and Drug Administration
Patient and Consumer Warning about Potential Serious Risks of Harm following Use of Unapproved Products from Human Cells or Tissues — U.S. Food and Drug Administration
Safe Injection Practices and Your Health — Centers for Disease Control and Prevention
Best questions to ask when considering a cosmetic treatment — American Academy of Dermatology
Other Services
Explore additional treatments offered at JD Clinic.

